185 related articles for article (PubMed ID: 21055143)
1. [Effects of immune modulation therapy on cardiac function in aged patients with chronic heart failure].
Cao XJ; Li YF; Cao FF; Shi ST; Wang G; Zhang LJ; Liu F
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Aug; 38(8):734-8. PubMed ID: 21055143
[TBL] [Abstract][Full Text] [Related]
2. Thymopentin improves cardiac function in older patients with chronic heart failure.
Xiaojing C; Yanfang L; Yanqing G; Fangfang C
Anatol J Cardiol; 2017 Jan; 17(1):24-30. PubMed ID: 27564775
[TBL] [Abstract][Full Text] [Related]
3. [Effects of phosphocreatine on plasma brain natriuretic peptide level in elderly patients with chronic congestive heart failure].
Du XH; Liang FY; Zhao XW
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):154-5, 159. PubMed ID: 19218138
[TBL] [Abstract][Full Text] [Related]
4. Effect of immune modulation therapy on cardiac function and T-bet/GATA-3 gene expression in aging male patients with chronic cardiac insufficiency.
Han LN; Guo SL; Li TL; Ding GL; Zhang YJ; Ma JL
Immunotherapy; 2013 Feb; 5(2):143-53. PubMed ID: 23413906
[TBL] [Abstract][Full Text] [Related]
5. [Effect of Shenqi Fuzheng injection (SFI) on immune function in patients with congestive heart failure].
Liu H; Wu X; Zhang Y; Lian W
Zhong Yao Cai; 2005 Sep; 28(9):854-6. PubMed ID: 16447880
[TBL] [Abstract][Full Text] [Related]
6. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of high-sensitivity C-reactive protein in patients with chronic heart failure.
Xue C; Feng Y; Wo J; Li Y
N Z Med J; 2006 Nov; 119(1245):U2314. PubMed ID: 17146489
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.
Yamada T; Node K; Mine T; Morita T; Kioka H; Tsukamoto Y; Tamaki S; Masuda M; Okuda K; Fukunami M
Am Heart J; 2007 Jun; 153(6):1055.e1-8. PubMed ID: 17540209
[TBL] [Abstract][Full Text] [Related]
9. Correlates of B-type natriuretic peptide and 6-min walk in heart failure patients.
Hogenhuis J; Jaarsma T; Voors AA; Hillege HL; Lesman I; van Veldhuisen DJ
Int J Cardiol; 2006 Mar; 108(1):63-7. PubMed ID: 16516699
[TBL] [Abstract][Full Text] [Related]
10. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study on characteristics of congestive heart failure patients with preserved versus abnormal left ventricular systolic function and evaluation effects of therapy].
Zhan H; Tse HF; Cao JM; Lau CP
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Apr; 18(4):210-5. PubMed ID: 16647010
[TBL] [Abstract][Full Text] [Related]
12. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
[TBL] [Abstract][Full Text] [Related]
13. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
[TBL] [Abstract][Full Text] [Related]
14. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
[TBL] [Abstract][Full Text] [Related]
15. Cytokine activation and disease progression in patients with stable moderate chronic heart failure.
Tanner H; Mohacsi P; Fuller-Bicer GA; Rieben R; Meier B; Hess O; Hullin R
J Heart Lung Transplant; 2007 Jun; 26(6):622-9. PubMed ID: 17543787
[TBL] [Abstract][Full Text] [Related]
16. [The clinical value of B-type natriuretic peptide in the diagnosis of left heart failure].
Zhao XY; Yang YJ; Zhang J; Dang AM; Ni XH; Huang J; Kang S; Ma WH; Zhao DY
Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1165-9. PubMed ID: 16796855
[TBL] [Abstract][Full Text] [Related]
17. [Application value of combining brain natriuretic peptide, creatine phosphokinase and echocardiogram in the evaluation of polymyositis-related chronic heart failure].
Yin G; Mao L; Cen XM; Yang M; Xie QB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 42(5):646-8, 660. PubMed ID: 22007490
[TBL] [Abstract][Full Text] [Related]
18. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
[TBL] [Abstract][Full Text] [Related]
19. Different characteristics of chronic heart failure (CHF) in elderly diabetics and non-diabetics.
Romeo R; Scalisi C; Tafuri L; Romeo A; Maugeri D; Sorace R
Arch Gerontol Geriatr; 2010; 50(1):101-4. PubMed ID: 19371958
[TBL] [Abstract][Full Text] [Related]
20. No effect of group-based aerobic interval training on N-terminal pro- B-type natriuretic peptide levels in patients with chronic heart failure.
Nilsson BB; Westheim A; Risberg MA; Arnesen H; Seljeflot I
Scand Cardiovasc J; 2010 Aug; 44(4):223-9. PubMed ID: 20636229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
